Morrison & Foerster LLP
Chroman derivatives
The invention relates to novel chroman derivatives, stereoisomers and pharmaceutically acceptable salts of Formula Iwherein the substituents are as defined in the specification. They are useful in the treatment of disorders mediated by lipoxygenase, such as immune diseases, respiratory diseases and cardiovascular diseases, as well as in the treatment of neurodegenerative disorders and/or mitochondria) disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.
Ampere Life Sciences, Inc.
C A A A A A C A C A A A A A A A A A A A A A C A A A A A C A C A C C C C A A A C C A A
C07D A61P A61P A61P A61K A61P C07D A61P C07D A61P A61K A61P A61P A61P A61P A61P A61K A61P A61P A61P A61P A61P C07D A61P A61K A61P A61P A61P C07D A61P C07D A61K C07D C07D C07D C07D A61P A61P A61K C07D C07D A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Bing Jian
Wang Chen